MX337348B - Metodos para purificar virus utilizando cromatografia de permeacion en gel. - Google Patents

Metodos para purificar virus utilizando cromatografia de permeacion en gel.

Info

Publication number
MX337348B
MX337348B MX2013012627A MX2013012627A MX337348B MX 337348 B MX337348 B MX 337348B MX 2013012627 A MX2013012627 A MX 2013012627A MX 2013012627 A MX2013012627 A MX 2013012627A MX 337348 B MX337348 B MX 337348B
Authority
MX
Mexico
Prior art keywords
methods
gel permeation
permeation chromatography
purifying viruses
viruses
Prior art date
Application number
MX2013012627A
Other languages
English (en)
Other versions
MX2013012627A (es
Inventor
Matthew C Coffey
Allison Hagerman
Roxna Kapadia
Sarah Serl
Original Assignee
Oncolytics Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncolytics Biotech Inc filed Critical Oncolytics Biotech Inc
Publication of MX2013012627A publication Critical patent/MX2013012627A/es
Publication of MX337348B publication Critical patent/MX337348B/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/34—Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424—Elution mode
    • B01D15/426—Specific type of solvent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/02—Separating microorganisms from their culture media
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12051—Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicinal Preparation (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)

Abstract

La presente invención se refiere a tampones de elusión y métodos para purificar virus utilizando la cromatografía de permeación en gel. Los métodos son útiles, por ejemplo, para incrementar la recuperación de un virus con una columna de cromatografía de permeación en gel. Los tampones que se usan en los métodos incluyen al menos un excipiente seleccionado de histidina o sacaros, un catión divalente, un detergente no iónico, y una solución salina amortiguada con fosfato.
MX2013012627A 2011-04-29 2012-04-27 Metodos para purificar virus utilizando cromatografia de permeacion en gel. MX337348B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161480561P 2011-04-29 2011-04-29
PCT/CA2012/000406 WO2012145837A1 (en) 2011-04-29 2012-04-27 Methods of purifying viruses using gel permeation chromatography

Publications (2)

Publication Number Publication Date
MX2013012627A MX2013012627A (es) 2014-05-13
MX337348B true MX337348B (es) 2016-02-29

Family

ID=47067091

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013012627A MX337348B (es) 2011-04-29 2012-04-27 Metodos para purificar virus utilizando cromatografia de permeacion en gel.

Country Status (15)

Country Link
US (1) US20120273424A1 (es)
EP (1) EP2702147B1 (es)
JP (1) JP6029651B2 (es)
KR (2) KR20140024406A (es)
CN (1) CN103492557B (es)
AU (1) AU2012248082B2 (es)
CA (1) CA2832367A1 (es)
DK (1) DK2702147T3 (es)
EA (1) EA201391605A1 (es)
ES (1) ES2822199T3 (es)
IL (1) IL228491A (es)
MX (1) MX337348B (es)
SG (1) SG194449A1 (es)
TW (1) TW201307561A (es)
WO (1) WO2012145837A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103269716B (zh) 2010-12-02 2015-05-27 昂科利蒂克斯生物科技公司 冻干病毒制剂
WO2012075379A2 (en) 2010-12-02 2012-06-07 Oncolytics Biotech Inc. Liquid viral formulations
PT3010537T (pt) * 2013-06-17 2019-12-03 De Staat Der Nederlanden Vert Door De Mini Van Vws Miniie Van Volksgezondheid Welzijn En Sport Métodos para a prevenção da agregação de componentes virais
CA3104392A1 (en) * 2018-07-04 2020-01-09 Probiogen Ag Method for purifying an enveloped virus
CN111812313B (zh) * 2020-06-22 2021-10-08 北京生物制品研究所有限责任公司 铝佐剂吸附型新型冠状病毒灭活疫苗中抗原的解离方法
CN114544815B (zh) * 2022-03-01 2023-10-27 中牧实业股份有限公司 一种山羊痘病毒的定量检测方法
CN116718524B (zh) * 2023-06-26 2025-11-07 西安交通大学 一种基于细胞膜色谱技术的病毒颗粒检测方法
HUP2400154A1 (hu) * 2024-02-29 2025-09-28 Pecsi Tudomanyegyetem Elúciós oldat és tisztítási eljárás

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
EP0410207B1 (en) * 1989-07-24 1997-01-22 Bayer Corporation Stabilization of highly purified proteins
ATE328068T1 (de) * 1994-05-16 2006-06-15 Merck & Co Inc Papillomavirus vakzine
WO1999041416A2 (en) * 1998-02-17 1999-08-19 Schering Corporation Compositions comprising viruses and methods for concentrating virus preparations
DK2253701T3 (da) 2001-03-16 2014-10-20 Oncolytics Biotech Inc Fremgangsmåde til ekstraktion af en virus fra en cellekultur
JP2005523722A (ja) 2002-04-30 2005-08-11 オンコリティクス バイオテック， インコーポレイティッド 改善されたウイルス精製方法
US7901921B2 (en) 2004-10-22 2011-03-08 Oncolytics Biotech Inc. Viral purification methods
EP1878791A1 (en) * 2006-07-11 2008-01-16 Bia Separations D.O.O. Method for influenza virus purification
CN101557824B (zh) * 2006-08-07 2012-01-25 财团法人化学及血清疗法研究所 活牛痘疫苗的制备方法
JP5577103B2 (ja) * 2007-03-12 2014-08-20 オンコリティクス バイオテク，インコーポレーテッド 改変配列を有するレオウイルス
EP2220116B1 (en) * 2007-11-12 2012-09-05 Theraclone Sciences, Inc. Compositions and methods for the therapy and diagnosis of influenza
US8227577B2 (en) * 2007-12-21 2012-07-24 Hoffman-La Roche Inc. Bivalent, bispecific antibodies
WO2012075379A2 (en) * 2010-12-02 2012-06-07 Oncolytics Biotech Inc. Liquid viral formulations
CN103269716B (zh) * 2010-12-02 2015-05-27 昂科利蒂克斯生物科技公司 冻干病毒制剂

Also Published As

Publication number Publication date
KR20140024406A (ko) 2014-02-28
JP2014516515A (ja) 2014-07-17
ES2822199T3 (es) 2021-04-29
AU2012248082B2 (en) 2015-08-20
MX2013012627A (es) 2014-05-13
SG194449A1 (en) 2013-12-30
AU2012248082A1 (en) 2013-05-09
JP6029651B2 (ja) 2016-11-24
EP2702147B1 (en) 2020-07-15
CN103492557B (zh) 2015-07-29
WO2012145837A1 (en) 2012-11-01
KR102151890B1 (ko) 2020-09-03
US20120273424A1 (en) 2012-11-01
KR20190026059A (ko) 2019-03-12
IL228491A (en) 2017-05-29
CN103492557A (zh) 2014-01-01
EA201391605A1 (ru) 2014-02-28
EP2702147A4 (en) 2014-11-05
IL228491A0 (en) 2013-12-31
EP2702147A1 (en) 2014-03-05
DK2702147T3 (da) 2020-09-28
CA2832367A1 (en) 2012-11-01
TW201307561A (zh) 2013-02-16

Similar Documents

Publication Publication Date Title
SG194449A1 (en) Methods of purifying viruses using gel permeation chromatography
MX392274B (es) Cartuchos utiles en limpieza de soluciones de dialisis.
WO2013078170A8 (en) Purification of anti-c-met antibodies
MX2015011199A (es) Agentes terapéuticos de csf1.
MX2015007888A (es) Compuestos antivirales.
PH12013501683A1 (en) Yeast-based therapeutic for chronic hepatitis b infection
ECSP13013060A (es) Composiciones de nucleasa terapéuticas y métodos
MX378747B (es) Complejos de proteínas de citomegalovirus.
MX2010004892A (es) Terapia de combinacion para tratar infecciones virales persistentes.
WO2011160024A3 (en) Compounds useful as antiviral agents, compositions, and methods of use
PH12014502628B1 (en) Compositions and methods related to the prevention and treatment of rabies infection
MX360245B (es) Composiciones que comprenden inmunoglobulinas de tipo secretor.
SI3660032T1 (sl) Postopki zajemanja in čiščenja beljakovin, izraženih v nesesalskem sistemu
BR112016022214A2 (pt) rnase para uso no tratamento ou prevenção de infecções virais
WO2013028334A3 (en) Use of small molecules in methods for purification of biomolecules
MX2019006568A (es) Eliminacion de ligandos lixiviados de purificacion de afinidad.
TN2013000388A1 (en) Anticoagulant antidotes
MX2018003080A (es) Cartuchos utiles en soluciones de dialisis de limpieza.
EA201590778A1 (ru) ОЧИСТКА КОМБИНИРОВАННОЙ ГАЛАКТОЦЕРЕБРОЗИД-β-ГАЛАКТОЗИДАЗЫ ЧЕЛОВЕКА (rhGALC)
WO2014160098A3 (en) Bordetella specific human recombinant antibodies and uses thereof
WO2012164003A3 (de) Solareinrichtung mit reflektorvorrichtung und reflektorvorrichtung
PH12014501285A1 (en) Liquid activation system
WO2015022470A3 (fr) Vaccins contre la maladie de lyme
ITAN20120093A1 (it) Dispositivo per la decantazione del vino.
MY171384A (en) Composition and methods related to the prevention and treatment of rabies infection

Legal Events

Date Code Title Description
FG Grant or registration